Free Trial
NASDAQ:OPTX

Syntec Optics Q4 2023 & Q1 2024 Earnings Report

Syntec Optics logo
$1.59 +0.27 (+20.45%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.58 -0.02 (-0.94%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Syntec Optics EPS Results

Actual EPS
-$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Syntec Optics Revenue Results

Actual Revenue
$6.26 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Syntec Optics Announcement Details

Quarter
Q4 2023 & Q1 2024
Time
N/A
Conference Call Date
Friday, May 24, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

Syntec Optics' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Syntec Optics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Syntec Optics and other key companies, straight to your email.

About Syntec Optics

Syntec Optics (NASDAQ:OPTX), Inc. is a medical device company that specializes in the design, development, and commercialization of fiberoptic airway management products. The company’s core offerings include reusable and single-use fiberoptic laryngoscope blades and endoscopes that provide clinicians with enhanced visualization during intubation procedures. These products address the growing need for reliable, flexible airway devices in both routine and difficult airway scenarios, supporting anesthesiologists, emergency physicians, and critical care teams in hospitals and surgical centers worldwide.

Founded in the early 2000s and headquartered in St. Louis, Missouri, Syntec Optics has built its reputation on rigorous engineering and strict regulatory compliance. The company’s portfolio features the Aurora™ family of fiberoptic blades and endoscope systems, which are cleared by the U.S. Food and Drug Administration and carry CE marking for distribution in European markets. Syntec Optics combines precision optics, advanced materials, and ergonomic design to meet the demanding requirements of airway management in a range of patient populations, from pediatrics to bariatric care.

Syntec Optics serves a global customer base through direct sales teams in North America and distribution partnerships across Europe, Asia, and Latin America. The company’s manufacturing operations adhere to ISO 13485 quality standards, with strategic production facilities in the United States and Asia. By maintaining close collaboration with hospital networks and clinician advisory boards, Syntec Optics continually refines its product features and usability, emphasizing single-use blade options to reduce cross-contamination risks and streamline procedural workflows.

Led by a management team with deep expertise in medical device commercialization and regulatory affairs, Syntec Optics focuses on innovation, quality assurance, and customer support. The company’s leadership emphasizes strategic investments in product development and global market expansion, positioning Syntec Optics as a trusted partner for healthcare providers seeking cutting-edge solutions in airway visualization and patient safety.

View Syntec Optics Profile

More Earnings Resources from MarketBeat